(19)
(11)
EP 1 011 705 A2
(12)
(88)
Date of publication A3:
15.04.1999
(43)
Date of publication:
28.06.2000
Bulletin 2000/26
(21)
Application number:
98939226.1
(22)
Date of filing:
05.08.1998
(51)
International Patent Classification (IPC)
7
:
A61K
38/00
,
A61K
38/04
,
A61K
38/08
(86)
International application number:
PCT/US9816/290
(87)
International publication number:
WO 9907/324
(
18.02.1999
Gazette 1999/07)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
(30)
Priority:
05.08.1997
US 914042
(71)
Applicant:
Watson Pharmaceuticals, Inc.
Corona, CA 91720 (US)
(72)
Inventor:
PRAKASH, Ramesh, K.
Salt Lake City, UT 84121 (US)
(74)
Representative:
Sexton, Jane Helen et al
J.A. KEMP & CO.14 South SquareGray's Inn
London WC1R 5LX
London WC1R 5LX (GB)
(54)
CONJUGATES TARGETED TO THE INTERLEUKIN-2 RECEPTOR